GlassScriptPhysician profile
Lindsey Sean Sharp
NPI 1578747952
$26,141.34
in general payments reported to CMS, 2019-2025
34 companies · $4,417 in 2025
The $4,417 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,821 · 2020: $2,049 · 2021: $7,401 · 2022: $1,335 · 2023: $3,187 · 2024: $933 · 2025: $4,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,007 · Food and Beverage: $3,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,007.24 |
| Food and Beverage | $3,529.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,348.52 | 2019-2024 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $8,474.64 | 2019-2025 | Linx Reflux Management System |
| Medtronic, INC. | $1,212.31 | 2021-2025 | Ligasure, Signia, Endo Gia Ultra |
| Novo Nordisk INC | $623.11 | 2019-2025 | Wegovy |
| Ethicon US, LLC | $575.97 | 2019-2025 | Endopath, Linx Reflux Management System, Enseal X1 |
| Abbvie INC. | $432.02 | 2019-2025 | Creon |
| Teleflex LLC | $310.43 | 2024-2025 | Titan Sgs Bailout Chuck, Titan Sgs |
| Covidien LP | $301.71 | 2019 | |
| Checkpoint Surgical, INC | $268.64 | 2021 | |
| Boston Scientific Corporation | $219.12 | 2025 | General - Biliary Devices, Overstitch Endoscopic Suturing System, Spyglass Discover |
| Baxter Healthcare | $204.96 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $147.49 | 2024-2025 | Zenpep |
| Lilly USA, LLC | $133.42 | 2023-2025 | Zepbound |
| Intra-Sana Laboratories | $129.59 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $126.45 | 2022-2025 | Gattex |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $116.30 | 2020-2022 | |
| Tela Bio, INC. | $112.23 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $73.79 | 2023 | Phasix Mesh, Arista Ah Flexitip |
| Currax Pharmaceuticals LLC | $44.25 | 2021-2024 | Contrave |
| Innocoll Pharmaceuticals Limited | $41.51 | 2021-2022 | |
| Tricoast Surgical Solutions LLC | $29.08 | 2024 | |
| Integra Lifesciences Corporation | $23.78 | 2025 | Integra, Surgimend, Omnigraft |
| Eisai INC. | $20.35 | 2019 | |
| Ambu INC. | $19.21 | 2022 | |
| Vivus LLC | $19.04 | 2025 | Pancreaze |
| Standard Bariatrics, INC. | $18.78 | 2022 | |
| Endo Pharmaceuticals INC. | $18.40 | 2020 | |
| Shire North American Group INC | $17.00 | 2019 | |
| Becton, Dickinson and Company | $15.50 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.28 | 2024 | Iovera, Zilretta, Exparel |
| Hologic Sales and Service, LLC | $13.88 | 2024 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $12.45 | 2022 | |
| Endogastric Solutions, INC | $11.16 | 2022 | |
| Echosens North America, INC. | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.